Immunohematology (62)

All Items

Molecular characterization of variant D antigen expression among 56,445 blood donors in East India: RHD variants in East India

Suvro Sankha Datta, Kshitij Srivastava, Mercy Rophina, Vinod Scaria, Yew-Wah Liew, Jenny Morrison, Glenda Maree Millard, Willy Albert Flegel
When is ABO-incompatible plasma safe to transfuse? Defining an empirical estimation of anti-A/anti-B in ABO incompatible plasma-containing blood products: Transfusion of ABO-incompatible plasma

Chenyue Shen, Jesper Bengtsson, Magnus Jöud, Jill R. Storry, Jens Kjeldsen-Kragh
Partial s antigen expression in GP(B-A-B) hybrid glycophorins and the corresponding in vitro expression study: Partial s antigen expression in GP(B-A-B)

Ling Wei, Siying Zhu, Jizhi Wen, Zhijian Liao, Shuangshuang Jia, Yanli Ji
Post-transplant pediatric autoimmune hemolytic anemia: donor vs donor or recipient vs self? Post-transplant pediatric AIHA

Alessandra Bernardi, Pierpaolo Berti, Elisabetta Cicchetti, Fabiola Landi, Ottavia Porzio
Identification of a novel ABO*O.01.01 allele with c.801G>T mutation in a Chinese A2 subtype individual: A novel ABO*O.01.01 allele with c.801G>T

Chonghe Xu, Zhongqi Zhu, Mei Zhu, Wei Xu
CD36 antibodies in isoimmunised African-origin pregnant women: three years experience in Spain: CD36 antibodies in isoimmunised African-origin pregnant women

Carme Canals, Cecilia Gonzalez-Santesteban, Immaculada Vinyets, Mercedes Gracia, Neus Boto, Marta Salgado, Immaculada Moreno, Marta Rodríguez-Aliberas, Enric Casanovas, Eduard Muñiz-Diaz, Núria Nogués
Rh disease in Mexico: evaluating regional and institutional differences in treatment availability and disease management: Rh disease awareness in Mexico

Jessica Ding, Celina Montemayor-Garcia, Brie A. Stotler, Steven L. Spitalnik, José Antonio Ayala Méndez
ELP protocol: an original approach for the mitigation of anti-CD38 interference: ELP protocol in the mitigation of anti-CD38 interference

Erica Maiorana, Maria Bortolati, Steluta Croitoru, Gledis Llanaj, Cinzia Ongaro, Eva Polga, Melissa Salvo, Alessandra Sandini, Krizia Succoli, Tiziana Tortomasi, Giacomina Vicino, Francesco Fiorin
A case of trisomy 9 with mixed-field ABO blood type: Trisomy 9 with mixed-field ABO blood type

Sena Fujii, Yuji Shimura, Keiichi Shigehara, Yuji Sasada, Tohru Inaba
Description of the first case of c.137-8C>T GYPB mutation not associated to the GYPB(P2) allele: c.137-8C>T GYPB mutation not associated to the GYPB(P2) allele

Luca Collodel, Gianluca Gessoni, Tommaso Mancuso
Defining the breakpoints of hybrid blood group alleles

Gregory A. Denomme
Single-exon fetal RHD genotyping: a 31-month follow up in the obstetric population of Western Sweden: Follow up on fetal RHD genotyping in Western Sweden

Cecilia Pardi, Åsa Hellberg, Pauline Isakson
Patients with red cell antibodies: registries improve patient care by increasing patient safety, reducing costs, and enabling health information exchange: Towards health informatics for patients with red cell antibodies

Willy A. Flegel
Genomic characterisation of clinically significant blood group variants in Aboriginal Australians: Blood group diversity in Aboriginal Australians

Sudhir Jadhao, Candice Davison, Eileen Roulis, Simon Lee, Tamika Campbell, Reece Griffin, Maree Toombs, Alex Brown, Maree Perry, Bushra Nasir, David O. Irving, Catherine A. Hyland, Robert L. Flower, Shivashankar H. Nagaraj
Identification of the novel c.300C>G variation on the ABO*A1.02 allele associated with an AweakB phenotype: A new variant A allele on ABO*A1.02

Yuqing Shen, Junshun Gong, Yuyu Zhang, Naizhu Su, Lou Can, Jiaming Li, Dong Xiang, Xiaohong Cai, Hang Lei
Noninvasive fetal blood group antigen genotyping: Noninvasive fetal blood group antigen genotyping

Frederik Banch Clausen, C Ellen van der Schoot
First investigation of RH gene polymorphism in patients with sickle cell disease and associated blood donors in Cameroon, Central Africa: RH gene polymorphism in Cameroon

Jeanne Manga Messina Mbeti, Caroline Bénech, Françoise Ngo Sack, Estelle Wete, Hortense Ngnegni, Simon Noël Ateba, Jules Tchatchueng, Alexandre Njan Nloga, Yann Fichou
The -72G>A nucleotide substitution impairs transcription of the ABO gene via reduction of promoter activity: Substitution mutation leads to the “3” subgroup phenotype

Hang Lei, Jiewei Zheng, Dong Xiang, Hui Zhang, Xuefeng Wang, Xiaohong Cai
Characterization of GYP(B-A-B) hybrid glycophorins among Thai blood donors with Mia-positive phenotypes: Characterization of GYP(B-A-B) hybrids among Thais

Oytip Nathalang, Piyathida Khumsuk, Wanlapa Chaibangyang, Kamphon Intharanut
Pretreatment with Daudi cells eliminates anti-CD47 monoclonal antibody interference in immunohematology testing: Pretreatment with Daudi cells in immunohematology testing

Hua Wei, Ying Cui, Dongxia Ren, Jiang Xia, Wenda Fu, Shijie Mu, Longfei Yang, Jie Chen
Use of a recombinant deacetylase to convert A1 red blood cells to the acquired B phenotype for quality control purposes: Making acquired B test cells

Jennifer Ricci Hagman, Peter Rahfeld, Stephen G. Withers, Jayachandran N. Kizhakkedathu , Martin L. Olsson, Jill R. Storry
Aplastic anemia after SARS-CoV-2 infection or vaccines: case series and literature review: Aplastic anemia and SARS-CoV-2

Bruno Fattizzo, Raffaella Pasquale, Giorgio Aleberto Croci, Loredana Pettine, Giulio Cassanello, Wilma Barcellini
Breakpoint regions of an RHD-CE(4-9)-D allele and a rare JK allele in a Pacific Islander individual: RHD-CE(4-9)-D hybrid and SLC14A1 null alleles

Kshitij Srivastava, Marina Ursula Bueno, Willy Albert Flegel
A novel method for antibody specificity identification using microscale direct antiglobulin test-positive red cells: Antibody identification of DAT positive red cells

Yuyu Zhang, Dong Xiang
Genetic and mechanistic evaluation of an individual with para-Bombay phenotype associated with a compound heterozygote comprising two novel FUT1 variants: Molecular mechanisms of para-Bombay phenotype

Yanling Ying, Xiaozhen Hong, Jingjing Zhang, Kairong Ma, Xianguo Xu, Faming Zhu

62 Items

Submit an Article

Announcements

Winter Closure

The Editorial Office will be closed from December 31 to January 7, 2026.

Season’s greetings to all our readers, authors, and reviewers.

SIMTI 2026

46° Convegno Nazionale di Studi di Medicina Trasfusionale - Abstract Book (in Italian)

SETS 2026

35° Congreso de la Sociedad Española de Transfusión Sanguínea y Terapia Celular - SETS - Abstract Book (in Spanish), is online (https://www.bloodtransfusion.it/bt/issue/view/81).

Madrid, 4-6 June 2026.

Editorial Office Closure Notice

Please note that the BT Editorial Office will be closed until August 26, 2026.

During this period, responses to inquiries and the processing of manuscripts may be delayed. All editorial activities will resume as usual after this date.

Thank you for your understanding.

Best regards,
BT Editorial Office

Impact Factor 2025

We are pleased to announce that Blood Transfusion has achieved a 2025 Impact Factor of 2.7.

Immunohematology (62)

All Items

Molecular characterization of variant D antigen expression among 56,445 blood donors in East India: RHD variants in East India

When is ABO-incompatible plasma safe to transfuse? Defining an empirical estimation of anti-A/anti-B in ABO incompatible plasma-containing blood products: Transfusion of ABO-incompatible plasma

Partial s antigen expression in GP(B-A-B) hybrid glycophorins and the corresponding in vitro expression study: Partial s antigen expression in GP(B-A-B)

Post-transplant pediatric autoimmune hemolytic anemia: donor vs donor or recipient vs self? Post-transplant pediatric AIHA

Identification of a novel ABOO.01.01 allele with c.801G>T mutation in a Chinese A2 subtype individual: A novel ABOO.01.01 allele with c.801G>T

CD36 antibodies in isoimmunised African-origin pregnant women: three years experience in Spain: CD36 antibodies in isoimmunised African-origin pregnant women

Rh disease in Mexico: evaluating regional and institutional differences in treatment availability and disease management: Rh disease awareness in Mexico

ELP protocol: an original approach for the mitigation of anti-CD38 interference: ELP protocol in the mitigation of anti-CD38 interference

A case of trisomy 9 with mixed-field ABO blood type: Trisomy 9 with mixed-field ABO blood type

Description of the first case of c.137-8C>T GYPB mutation not associated to the GYPB(P2) allele: c.137-8C>T GYPB mutation not associated to the GYPB(P2) allele

Defining the breakpoints of hybrid blood group alleles

Single-exon fetal RHD genotyping: a 31-month follow up in the obstetric population of Western Sweden: Follow up on fetal RHD genotyping in Western Sweden

Patients with red cell antibodies: registries improve patient care by increasing patient safety, reducing costs, and enabling health information exchange: Towards health informatics for patients with red cell antibodies

Genomic characterisation of clinically significant blood group variants in Aboriginal Australians: Blood group diversity in Aboriginal Australians

Identification of the novel c.300C>G variation on the ABOA1.02 allele associated with an AweakB phenotype: A new variant A allele on ABOA1.02

Noninvasive fetal blood group antigen genotyping: Noninvasive fetal blood group antigen genotyping

First investigation of RH gene polymorphism in patients with sickle cell disease and associated blood donors in Cameroon, Central Africa: RH gene polymorphism in Cameroon

The -72G>A nucleotide substitution impairs transcription of the ABO gene via reduction of promoter activity: Substitution mutation leads to the “3” subgroup phenotype

Characterization of GYP(B-A-B) hybrid glycophorins among Thai blood donors with Mia-positive phenotypes: Characterization of GYP(B-A-B) hybrids among Thais

Pretreatment with Daudi cells eliminates anti-CD47 monoclonal antibody interference in immunohematology testing: Pretreatment with Daudi cells in immunohematology testing

Use of a recombinant deacetylase to convert A1 red blood cells to the acquired B phenotype for quality control purposes: Making acquired B test cells

Aplastic anemia after SARS-CoV-2 infection or vaccines: case series and literature review: Aplastic anemia and SARS-CoV-2

Breakpoint regions of an RHD-CE(4-9)-D allele and a rare JK allele in a Pacific Islander individual: RHD-CE(4-9)-D hybrid and SLC14A1 null alleles

A novel method for antibody specificity identification using microscale direct antiglobulin test-positive red cells: Antibody identification of DAT positive red cells

Genetic and mechanistic evaluation of an individual with para-Bombay phenotype associated with a compound heterozygote comprising two novel FUT1 variants: Molecular mechanisms of para-Bombay phenotype

Announcements

Winter Closure

SIMTI 2026

SETS 2026

Editorial Office Closure Notice

Impact Factor 2025

Information

PLASTIC RECONSTRUCTIVE AND REGENERATIVE SURGERY

Immunohematology (62)

All Items

Molecular characterization of variant D antigen expression among 56,445 blood donors in East India: RHD variants in East India

When is ABO-incompatible plasma safe to transfuse? Defining an empirical estimation of anti-A/anti-B in ABO incompatible plasma-containing blood products: Transfusion of ABO-incompatible plasma

Partial s antigen expression in GP(B-A-B) hybrid glycophorins and the corresponding in vitro expression study: Partial s antigen expression in GP(B-A-B)

Post-transplant pediatric autoimmune hemolytic anemia: donor vs donor or recipient vs self? Post-transplant pediatric AIHA

Identification of a novel ABO*O.01.01 allele with c.801G>T mutation in a Chinese A2 subtype individual: A novel ABO*O.01.01 allele with c.801G>T

CD36 antibodies in isoimmunised African-origin pregnant women: three years experience in Spain: CD36 antibodies in isoimmunised African-origin pregnant women

Rh disease in Mexico: evaluating regional and institutional differences in treatment availability and disease management: Rh disease awareness in Mexico

ELP protocol: an original approach for the mitigation of anti-CD38 interference: ELP protocol in the mitigation of anti-CD38 interference

A case of trisomy 9 with mixed-field ABO blood type: Trisomy 9 with mixed-field ABO blood type

Description of the first case of c.137-8C>T GYPB mutation not associated to the GYPB(P2) allele: c.137-8C>T GYPB mutation not associated to the GYPB(P2) allele

Defining the breakpoints of hybrid blood group alleles

Single-exon fetal RHD genotyping: a 31-month follow up in the obstetric population of Western Sweden: Follow up on fetal RHD genotyping in Western Sweden

Patients with red cell antibodies: registries improve patient care by increasing patient safety, reducing costs, and enabling health information exchange: Towards health informatics for patients with red cell antibodies

Genomic characterisation of clinically significant blood group variants in Aboriginal Australians: Blood group diversity in Aboriginal Australians

Identification of the novel c.300C>G variation on the ABO*A1.02 allele associated with an AweakB phenotype: A new variant A allele on ABO*A1.02

Noninvasive fetal blood group antigen genotyping: Noninvasive fetal blood group antigen genotyping

First investigation of RH gene polymorphism in patients with sickle cell disease and associated blood donors in Cameroon, Central Africa: RH gene polymorphism in Cameroon

The -72G>A nucleotide substitution impairs transcription of the ABO gene via reduction of promoter activity: Substitution mutation leads to the “3” subgroup phenotype

Characterization of GYP(B-A-B) hybrid glycophorins among Thai blood donors with Mia-positive phenotypes: Characterization of GYP(B-A-B) hybrids among Thais

Pretreatment with Daudi cells eliminates anti-CD47 monoclonal antibody interference in immunohematology testing: Pretreatment with Daudi cells in immunohematology testing

Use of a recombinant deacetylase to convert A1 red blood cells to the acquired B phenotype for quality control purposes: Making acquired B test cells

Aplastic anemia after SARS-CoV-2 infection or vaccines: case series and literature review: Aplastic anemia and SARS-CoV-2

Breakpoint regions of an RHD-CE(4-9)-D allele and a rare JK allele in a Pacific Islander individual: RHD-CE(4-9)-D hybrid and SLC14A1 null alleles

A novel method for antibody specificity identification using microscale direct antiglobulin test-positive red cells: Antibody identification of DAT positive red cells

Genetic and mechanistic evaluation of an individual with para-Bombay phenotype associated with a compound heterozygote comprising two novel FUT1 variants: Molecular mechanisms of para-Bombay phenotype

Announcements

Winter Closure

SIMTI 2026

SETS 2026

Editorial Office Closure Notice

Impact Factor 2025

Information

Banner

Identification of a novel ABOO.01.01 allele with c.801G>T mutation in a Chinese A2 subtype individual: A novel ABOO.01.01 allele with c.801G>T

Identification of the novel c.300C>G variation on the ABOA1.02 allele associated with an AweakB phenotype: A new variant A allele on ABOA1.02